1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure

BACKGROUND AND AIMS: 1,5-Anhydroglucitol (1,5AG) activity has been reported in chronic liver disease. Hepatitis B virus (HBV)-related acute-on-chronic liver failure (HBV-ACLF) patients have a high mortality. We aimed to discover the relationship between serum 1,5AG and the prognosis of HBV-ACLF. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lingjian, Zhao, Yalei, Xie, Zhongyang, Xiao, Lanlan, Hu, Qingqing, Li, Qian, Tang, Shima, Wang, Jie, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396314/
https://www.ncbi.nlm.nih.gov/pubmed/36062285
http://dx.doi.org/10.14218/JCTH.2021.00347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396314/
https://www.ncbi.nlm.nih.gov/pubmed/36062285
http://dx.doi.org/10.14218/JCTH.2021.00347

Ejemplares similares